{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,9]],"date-time":"2026-01-09T19:27:38Z","timestamp":1767986858973,"version":"3.49.0"},"reference-count":31,"publisher":"Wiley","issue":"11","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":1400,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2011,11]]},"DOI":"10.1111\/j.1348-0421.2011.00376.x","type":"journal-article","created":{"date-parts":[[2011,8,10]],"date-time":"2011-08-10T17:41:34Z","timestamp":1312998094000},"page":"798-808","source":"Crossref","is-referenced-by-count":20,"title":["Evaluation of immunogenicity and protective efficacy against Mycobacterium tuberculosis infection elicited by recombinant Mycobacterium bovis BCG expressing human Interleukin-12p70 and Early Secretory Antigen Target-6 fusion protein"],"prefix":"10.1111","volume":"55","author":[{"given":"Yihao","family":"Deng","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lang","family":"Bao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaoling","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2011,11,10]]},"reference":[{"key":"10.1111\/j.1348-0421.2011.00376.x-BIB1|cit1","unstructured":"WHO 2009 Global tuberculosis control: A short update to the 2009 report 426"},{"key":"10.1111\/j.1348-0421.2011.00376.x-BIB2|cit2","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1126\/science.1184784","article-title":"Tuberculosis: what we don't know can, and does, hurt us","volume":"328","author":"Russell","year":"2010","journal-title":"Science"},{"key":"10.1111\/j.1348-0421.2011.00376.x-BIB3|cit3","first-page":"70","article-title":"The BCG controversy: a reappraisal of the protective effect against tuberculosis and leprosy","volume":"48","author":"Zodpey","year":"2004","journal-title":"Indian J Public Health"},{"key":"10.1111\/j.1348-0421.2011.00376.x-BIB4|cit4","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1111\/j.1574-6968.2000.tb09304.x","article-title":"Recombinant BCG approach for development of vaccines cloning and expression of immunodominant antigens of M. tuberculosis","volume":"190","author":"Dhar","year":"2000","journal-title":"FEMS Microbiol Lett"},{"key":"10.1111\/j.1348-0421.2011.00376.x-BIB5|cit5","first-page":"57","article-title":"Modified vaccinia Ankara-expressing Ag85A, a novel tuberculosis vaccine, is safe in adolescents and children, and induces polyfunctional CD4+ cells","volume":"58","author":"Scriba","year":"2010","journal-title":"Eur J Immunol"},{"key":"10.1111\/j.1348-0421.2011.00376.x-BIB6|cit6","doi-asserted-by":"crossref","first-page":"8047","DOI":"10.4049\/jimmunol.0801592","article-title":"Tuberculosis subunit vaccination provides long-term protective immunity characterized by multifunctional CD4 memory T cells","volume":"182","author":"Lindenstrom","year":"2009","journal-title":"J Immunol"},{"key":"10.1111\/j.1348-0421.2011.00376.x-BIB7|cit7","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1128\/CVI.00237-09","article-title":"A multicistronic DNA vaccine induces significant protection against tuberculosis in mice and offers flexibility in the expressed antigen repertoire","volume":"16","author":"Mir","year":"2009","journal-title":"Clin Vaccine Immunol"},{"key":"10.1111\/j.1348-0421.2011.00376.x-BIB8|cit8","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1007\/s00430-008-0098-x","article-title":"Evaluation of a recombinant BCG expressing antigAg85B and PPE protein Rv3425 from DNA segment RD11 of Mycobacterium tuberculosis in C57BL\/6 mice","volume":"198","author":"Wang","year":"2009","journal-title":"Med Microbiol Immunol"},{"key":"10.1111\/j.1348-0421.2011.00376.x-BIB9|cit9","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1046\/j.1440-1711.2002.01078.x","article-title":"Manipulation of immune responses to Mycobacterium bovis by vaccination with IL-2-and IL-18-secreting recombinant bacillus Calmette Guerin","volume":"80","author":"Young","year":"2002","journal-title":"Immunol Cell Biol"},{"key":"10.1111\/j.1348-0421.2011.00376.x-BIB10|cit10","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1111\/j.1574-695X.2007.00322.x","article-title":"Recombinant BCG coexpressing Ag85B, ESAT-6 and mouse-IFN-gamma confers effective protection against Mycobacterium tuberculosis in C57BL\/6 mice","volume":"51","author":"Xu","year":"2007","journal-title":"FEMS Immunol Med Microbiol"},{"key":"10.1111\/j.1348-0421.2011.00376.x-BIB11|cit11","doi-asserted-by":"crossref","first-page":"1520","DOI":"10.1126\/science.284.5419.1520","article-title":"Comparative genomics of BCG vaccines by whole-genome DNA microarray","volume":"284","author":"Behr","year":"1999","journal-title":"Science"},{"key":"10.1111\/j.1348-0421.2011.00376.x-BIB12|cit12","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1128\/IAI.64.1.16-22.1996","article-title":"Evidence for occurrence of the ESAT-6 protein in Mycobacterium tuberculosis and virulent Mycobacterium bovis and for its absence in Mycobacterium bovis BCG","volume":"64","author":"Harboe","year":"1996","journal-title":"Infect Immun"},{"key":"10.1111\/j.1348-0421.2011.00376.x-BIB13|cit13","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1084\/jem.173.4.869","article-title":"Induction of interferon gamma production by natural killer cell stimulatory factor: characterization of the responder cells and synergy with other inducers","volume":"173","author":"Chan","year":"1991","journal-title":"J Exp Med"},{"key":"10.1111\/j.1348-0421.2011.00376.x-BIB14|cit14","doi-asserted-by":"crossref","first-page":"2559","DOI":"10.1084\/jem.183.6.2559","article-title":"Interleukin-12 primes human CD4 and CD8 T cell clones for high production of both interferon gamma and interleukin-10","volume":"183","author":"Gerosa","year":"1996","journal-title":"J Exp Med"},{"key":"10.1111\/j.1348-0421.2011.00376.x-BIB15|cit15","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1038\/nri1001","article-title":"Interleukin-12 and the regulation of innate resistance and adaptive immunity","volume":"3","author":"Trinchieri","year":"2003","journal-title":"Nat Rev Immunol"},{"key":"10.1111\/j.1348-0421.2011.00376.x-BIB16|cit16","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1038\/351456a0","article-title":"New use of BCG for recombinant vaccines","volume":"351","author":"Stover","year":"1991","journal-title":"Nature"},{"key":"10.1111\/j.1348-0421.2011.00376.x-BIB17|cit17","doi-asserted-by":"crossref","first-page":"1656","DOI":"10.1128\/IAI.71.4.1656-1661.2003","article-title":"Virulence, immunogenicity, and protective efficacy of two recombinant Mycobacterium bovis bacillus Calmette-Guerin strains expressing the antigen ESAT-6 from Mycobacterium tuberculosis","volume":"71","author":"Bao","year":"2003","journal-title":"Infect Immun."},{"key":"10.1111\/j.1348-0421.2011.00376.x-BIB18|cit18","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1084\/jem.175.4.1111","article-title":"Killing of virulent Mycobacterium tuberculosis by reactive nitrogen intermediates produced by activated murine macrophages","volume":"175","author":"Chan","year":"1992","journal-title":"J Exp Med"},{"key":"10.1111\/j.1348-0421.2011.00376.x-BIB19|cit19","doi-asserted-by":"crossref","first-page":"5817","DOI":"10.1128\/IAI.00793-08","article-title":"Primary activation of antigen-specific na\u00efve CD4+ and CD8+ T cells following intranasal vaccination with recombinant bacteria","volume":"76","author":"Ciabattini","year":"2008","journal-title":"Infect Immun"},{"key":"10.1111\/j.1348-0421.2011.00376.x-BIB20|cit20","doi-asserted-by":"crossref","first-page":"4185","DOI":"10.4049\/jimmunol.174.7.4185","article-title":"Maintenance of pulmonary Th1 effector function in chronic tuberculosis requires persistent IL-12 production","volume":"174","author":"Feng","year":"2005","journal-title":"J Immunol"},{"key":"10.1111\/j.1348-0421.2011.00376.x-BIB21|cit21","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1038\/nri1920","article-title":"Envisioning future stratedies for vaccination against tuberculosis","volume":"6","author":"Kaufmann","year":"2006","journal-title":"Nat Rev Immunol"},{"key":"10.1111\/j.1348-0421.2011.00376.x-BIB22|cit22","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1084\/jem.160.2.600","article-title":"Activation of human macrophages. Comparison of other cytokines with interferon-gamma","volume":"160","author":"Nathan","year":"1984","journal-title":"J Exp Med"},{"key":"10.1111\/j.1348-0421.2011.00376.x-BIB23|cit23","doi-asserted-by":"crossref","first-page":"6156","DOI":"10.1128\/IAI.69.10.6156-6164.2001","article-title":"Enhancement of innate immunity against Mycobacterium infection by immunostimulatory DNA is mediated by indoleamine2,3-dioxygenase","volume":"69","author":"Hayashi","year":"2001","journal-title":"Infect Immun"},{"key":"10.1111\/j.1348-0421.2011.00376.x-BIB24|cit24","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/j.tube.2004.05.001","article-title":"Morphometric analysis of Th(1) and Th(2) cytokine expression in human pulmonary","volume":"84","author":"Bai","year":"2004","journal-title":"Tuberculosis (Edinb"},{"key":"10.1111\/j.1348-0421.2011.00376.x-BIB25|cit25","doi-asserted-by":"crossref","first-page":"327","DOI":"10.2174\/156652407780598557","article-title":"Th2 cytokine in susceptibility to tuberculosis","volume":"7","author":"Rook","year":"2007","journal-title":"Curr Mol Med"},{"key":"10.1111\/j.1348-0421.2011.00376.x-BIB26|cit26","first-page":"668s","article-title":"Functions of T-cell subsets and cytokines in mycobacterial infections","volume":"20","author":"Munk","year":"1995","journal-title":"Eur Respir J Suppl"},{"key":"10.1111\/j.1348-0421.2011.00376.x-BIB27|cit27","doi-asserted-by":"crossref","first-page":"4296","DOI":"10.4049\/jimmunol.176.7.4296","article-title":"Contribution of CD8+ T cells to control of Mycobacterium tuberculosis infection","volume":"176","author":"Sud","year":"2006","journal-title":"J Immunol"},{"key":"10.1111\/j.1348-0421.2011.00376.x-BIB28|cit28","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.tube.2008.09.008","article-title":"Protective efficacy of recombinant BCG Tokyo (Ag85A) in rhesus monkeys (Macaca mulatta) infected infected intratracheally with H37Rv Mycobacterium tuberculosis","volume":"89","author":"Sugawara","year":"2009","journal-title":"Tuberculsisi (Edinb)"},{"key":"10.1111\/j.1348-0421.2011.00376.x-BIB29|cit29","doi-asserted-by":"crossref","first-page":"5137","DOI":"10.4049\/jimmunol.179.8.5137","article-title":"Mycobacterium bovis Bacillus Calmette-Guerin secteting active cathepsin S stimulates expression of mature MHC class II molecules and antigen presentation in human macrophages","volume":"179","author":"Soualhine","year":"2007","journal-title":"J Immunol"},{"key":"10.1111\/j.1348-0421.2011.00376.x-BIB30|cit30","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1111\/j.1574-695X.2009.00559.x","article-title":"Comparable studies of immunostimulating activities in vitro among Mycobacterium bovis bacillus Calmette-Guerin (BCG) substrains","volume":"56","author":"Hayashi","year":"2009","journal-title":"FEMS Immunol Med Microbiol"},{"key":"10.1111\/j.1348-0421.2011.00376.x-BIB31|cit31","doi-asserted-by":"crossref","first-page":"70","DOI":"10.4161\/hv.5.2.7210","article-title":"BCG vaccines: their mechanisms of attenuation and impact on safety and protective efficacy","volume":"5","author":"Liu","year":"2009","journal-title":"Human Vaccine"}],"container-title":["Microbiology and Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1348-0421.2011.00376.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/j.1348-0421.2011.00376.x\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,4]],"date-time":"2021-07-04T13:30:47Z","timestamp":1625405447000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1348-0421.2011.00376.x"}},"subtitle":["A novel tuberculosis vaccine"],"short-title":[],"issued":{"date-parts":[[2011,11]]},"references-count":31,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2011,11]]}},"URL":"https:\/\/doi.org\/10.1111\/j.1348-0421.2011.00376.x","relation":{},"ISSN":["0385-5600"],"issn-type":[{"value":"0385-5600","type":"print"}],"subject":[],"published":{"date-parts":[[2011,11]]}}}